Endpoints News Feb 4, 2026 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News Feb 3, 2026 'Turning around the Titanic': How the incoming PBM reforms will transform CMS
Endpoints News Feb 3, 2026 Ultragenyx unwraps data that may be central to its gene therapy resubmission
Endpoints News Feb 3, 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News Feb 3, 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News Feb 2, 2026 First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?